Literature DB >> 3875218

Liver cysts in autosomal-dominant polycystic kidney disease: clinical and computed tomographic study.

E Levine, L T Cook, J J Grantham.   

Abstract

Hepatic CT findings were analyzed in 44 patients with autosomal-dominant polycystic kidney disease and were correlated with liver and renal function tests and liver, splenic, and renal CT volume measurements. CT showed many large liver cysts in 31.8% of patients, small liver cysts in 25%, and no liver cysts in 43.2%. Patients with many large cysts often showed increased liver volumes. Splenic volumes did not differ significantly in patients with and without liver cysts, suggesting that portal hypertension is rarely associated with cystic liver disease. There was no correlation between severity of liver involvement and extent of renal cystic disease as determined from urea nitrogen and creatinine levels and renal volumes. Liver function tests were normal except in two patients, one with a cholangiocarcinoma, which may have arisen from a cyst, and the other with an infected liver cyst and chronic active hepatitis. Accordingly, if liver function tests are abnormal, an attempt should be made to identify complications of polycystic liver disease such as tumor, cyst infection, and biliary obstruction. Such complications are rare but may be seen in patients whose lives are prolonged by dialysis and renal transplantation. CT is a useful method for detecting liver cysts and identifying patients at risk for these complications.

Entities:  

Mesh:

Year:  1985        PMID: 3875218     DOI: 10.2214/ajr.145.2.229

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  16 in total

1.  Polycystic liver disease with obstructive jaundice: treatment with ultrasound-guided cyst aspiration.

Authors:  M E Lerner; J E Roshkow; A Smithline; C Ng
Journal:  Gastrointest Radiol       Date:  1992

2.  Positron emission tomography in the diagnostic pathway for intracystic infection in adpkd and "cystic" kidneys. a case series.

Authors:  Giorgina B Piccoli; Vincenzo Arena; Valentina Consiglio; Maria Chiara Deagostini; Ettore Pelosi; Anastasios Douroukas; Daniele Penna; Giancarlo Cortese
Journal:  BMC Nephrol       Date:  2011-09-29       Impact factor: 2.388

3.  Calcified hepatic and renal cysts in adult dominant polycystic kidney disease.

Authors:  B Coffin; A Hadengue; F Degos; J P Benhamou
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

4.  The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.

Authors:  Melahat Coban; Ayca Inci
Journal:  Int Urol Nephrol       Date:  2018-04-13       Impact factor: 2.370

Review 5.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 6.  Jaundice in Polycystic Liver Disease: More Than Meets the Eye.

Authors:  Danielle Brandman
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

Review 7.  Isolated polycystic liver disease.

Authors:  Qi Qian
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

8.  Treatment of highly symptomatic polycystic liver disease. Preliminary experience with a combined hepatic resection-fenestration procedure.

Authors:  K D Newman; V E Torres; J Rakela; D M Nagorney
Journal:  Ann Surg       Date:  1990-07       Impact factor: 12.969

9.  Treatment of polycystic liver disease with resection-fenestration and a new classification.

Authors:  Tuan-Jie Li; Hai-Bin Zhang; Jun-Hua Lu; Jun Zhao; Ning Yang; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

10.  Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment.

Authors:  W Uddin; J K Ramage; B Portmann; P Wilson; I Benjamin; K C Tan; R Williams
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.